|
LRRC16A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.662520E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.398070E-03 |
| Normal-vs-Stage2 |
8.962100E-02 |
| Normal-vs-Stage3 |
1.756930E-03 |
| Normal-vs-Stage4 |
1.101660E-02 |
| Stage1-vs-Stage2 |
4.793600E-01 |
| Stage1-vs-Stage3 |
6.699600E-01 |
| Stage1-vs-Stage4 |
9.790600E-01 |
| Stage2-vs-Stage3 |
3.845000E-01 |
| Stage2-vs-Stage4 |
6.140000E-01 |
| Stage3-vs-Stage4 |
7.560400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.837200E-03 |
| Normal-vs-AfricanAmerican |
4.897200E-01 |
| Normal-vs-Asian |
1.96967999999131E-05 |
| Caucasian-vs-AfricanAmerican |
2.703400E-01 |
| Caucasian-vs-Asian |
9.696000E-03 |
| AfricanAmerican-vs-Asian |
2.740000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.206430E-02 |
| Normal-vs-Female |
6.397600E-04 |
| Male-vs-Female |
5.023600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.084200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.184990E-03 |
| Normal-vs-Age(61-80Yrs) |
6.399900E-03 |
| Normal-vs-Age(81-100Yrs) |
6.862600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.157600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.005800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.724200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.693600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.202000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.075200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.761800E-01 |
| Classical-VS-Follicular |
1.031760E-04 |
| Classical-VS-Other |
8.008600E-01 |
| Classical-VS-Normal |
3.228200E-02 |
| Tall-VS-Follicular |
6.000300E-02 |
| Tall-VS-Other |
9.819600E-01 |
| Tall-VS-Normal |
3.075600E-02 |
| Follicular-VS-Other |
3.136200E-01 |
| Follicular-VS-Normal |
2.06499999999554E-06 |
| Other-VS-Normal |
2.598000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.011300E-04 |
| Normal-vs-N1 |
7.95690000000571E-05 |
| N0-vs-N1 |
2.584600E-01 |
|
|
